U.S. flag

An official website of the United States government

NM_000053.4(ATP7B):c.2333G>A (p.Arg778Gln) AND Wilson disease

Germline classification:
Pathogenic (8 submissions)
Last evaluated:
Dec 19, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000665805.14

Allele description [Variation Report for NM_000053.4(ATP7B):c.2333G>A (p.Arg778Gln)]

NM_000053.4(ATP7B):c.2333G>A (p.Arg778Gln)

Gene:
ATP7B:ATPase copper transporting beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q14.3
Genomic location:
Preferred name:
NM_000053.4(ATP7B):c.2333G>A (p.Arg778Gln)
HGVS:
  • NC_000013.11:g.51958333C>T
  • NG_008806.1:g.58162G>A
  • NM_000053.4:c.2333G>AMANE SELECT
  • NM_001005918.3:c.1870-726G>A
  • NM_001243182.2:c.2000G>A
  • NM_001330578.2:c.2122-726G>A
  • NM_001330579.2:c.2081G>A
  • NP_000044.2:p.Arg778Gln
  • NP_001230111.1:p.Arg667Gln
  • NP_001317508.1:p.Arg694Gln
  • NC_000013.10:g.52532469C>T
  • NM_000053.3:c.2333G>A
Protein change:
R667Q
Links:
dbSNP: rs28942074
NCBI 1000 Genomes Browser:
rs28942074
Molecular consequence:
  • NM_001005918.3:c.1870-726G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330578.2:c.2122-726G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000053.4:c.2333G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001243182.2:c.2000G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330579.2:c.2081G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
5

Condition(s)

Name:
Wilson disease (WND)
Synonyms:
Wilson's disease; Hepatolenticular degeneration
Identifiers:
MONDO: MONDO:0010200; MedGen: C0019202; Orphanet: 905; OMIM: 277900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000789984Counsyl
criteria provided, single submitter

(Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018))
Pathogenic
(Apr 24, 2017)
unknownclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Citation Link,

SCV000918605Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Nov 28, 2018)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Citation Link,

SCV001402302Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 19, 2023)
germlineclinical testing

PubMed (19)
[See all records that cite these PMIDs]

SCV001459729Natera, Inc.
no assertion criteria provided
Pathogenic
(Sep 16, 2020)
germlineclinical testing

SCV001977324Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 10, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004176463Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 1, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004216313Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Sep 30, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004845534All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Oct 30, 2023)
germlineclinical testing

PubMed (14)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown5not providednot provided108544not providedclinical testing
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson Disease.

Cheng N, Wang H, Wu W, Yang R, Liu L, Han Y, Guo L, Hu J, Xu L, Zhao J, Han Y, Liu Q, Li K, Wang X, Chen W.

Clin Genet. 2017 Jul;92(1):69-79. doi: 10.1111/cge.12951. Epub 2017 Feb 16.

PubMed [citation]
PMID:
27982432

Molecular analysis and diagnosis in Japanese patients with Wilson's disease.

Shimizu N, Nakazono H, Takeshita Y, Ikeda C, Fujii H, Watanabe A, Yamaguchi Y, Hemmi H, Shimatake H, Aoki T.

Pediatr Int. 1999 Aug;41(4):409-13.

PubMed [citation]
PMID:
10453196
See all PubMed Citations (28)

Details of each submission

From Counsyl, SCV000789984.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000918605.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

Variant summary: ATP7B c.2333G>A (p.Arg778Gln) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.2e-05 in 247080 control chromosomes (gnomAD and publications). c.2333G>A has been reported in the literature in multiple individuals affected with Wilson Disease (Cheng_2017, Dong_2016, Lu_2014, Mukherjee_2014, Wan_2010, Lepori_2007, Park_2007, Wu_2001, Chuang_1996). Individuals who are homozygous for the variant have been reported to present with neurological and hepato-neurological symptoms (Wan_2010). These data indicate that the variant is very likely to be associated with disease. Experimental evidence indicate a damaging impact of the variant on protein function; specifically, the variant caused reduced copper bound holo-Fet3p activity in ccc2 mutant yeast and only partially rescued mutant yeast in complementation assay (Forbes_1998). A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cites the variant as pathogenic. Additionally, a different variant at the same nucleotide and codon position has been described as a common pathogenic variant associated with Wilson disease (c.2333G>T, p.Arg778Leu), especially in the Asian population, supporting the functional importance of this position. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV001402302.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (19)

Description

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 778 of the ATP7B protein (p.Arg778Gln). This variant is present in population databases (rs28942074, gnomAD 0.03%). This missense change has been observed in individual(s) with Wilson disease (PMID: 11405812, 20931554, 21796144, 27022412). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 550914). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ATP7B protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects ATP7B function (PMID: 9837819). This variant disrupts the p.Arg778 amino acid residue in ATP7B. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10453196, 11243728, 11405812, 11479773, 16998622, 17160357, 20517649, 21682854, 23333878, 23518715, 25086856, 25988284, 27398169, 28212618). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV001459729.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genome-Nilou Lab, SCV001977324.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

From Neuberg Centre For Genomic Medicine, NCGM, SCV004176463.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The missense c.2333G>A (p.Arg778Gln) variant in ATP7B gene has been reported previously in multiple individuals affected with Wilson disease (Dong et al. 2016; Yu et al. 2017). Experimental studies have shown that this missense change affects ATP7B function and might result in a milder form of Wilson disease (Forbes & Cox 1998). The p.Arg778Gln variant is reported with an allele frequency of 0.003% in the gnomAD exomes database and is novel (not in any individuals) in 1000 Genomes database. This variant has been reported to the ClinVar database as Pathogenic (multiple submissions). The amino acid change p.Arg778Gln in ATP7B is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Arg at position 778 is changed to a Gln changing protein sequence and it might alter its composition and physico-chemical properties. Another variant [p.Arg778Leu] at this residue has previously been classified as pathogenic. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004216313.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004845534.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided5not providednot providedclinical testing PubMed (14)

Description

This missense variant replaces arginine with glutamine at codon 778 of the ATP7B protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Studies conducted in yeast have shown that this variant disrupted function in a complementation assay and caused temperature sensitivity (PMID: 9837819). This variant has been reported in many individuals affected with Wilson disease (PMID: 8782057, 11043508, 11405812, 17587212, 17949296, 20931554, 21796144, 23235335, 24094725, 24878384, 27022412, 28212618) and in an unaffected control (PMID: 11043508). In several of these individuals, this variant was reported in the homozygous state or compound heterozygous state with a know pathogenic variant in the same gene (PMID: 11405812, 20931554, 24878384, 27022412, 28212618). This variant has been identified in 8/249404 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided5not providednot providednot provided

Last Updated: Apr 20, 2024